As expected, the p‐RIP2 and p‐p38 levels were markedly increased in PBMCs from patients with CRC‐LM compared with those in PBMCs from healthy donors (Figure 5a,b), suggesting that activated NOD1 signalling had occurred in CRC‐LM. This evidence concerns the gene NOD1 and colorectal carcinoma.